Lanosterol Synthase (2,3-Oxidosqualene-Lanosterol Cyclase) (LSS) Peptide
Quick Overview for Lanosterol Synthase (2,3-Oxidosqualene-Lanosterol Cyclase) (LSS) Peptide (ABIN939661)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- KCPHVTEHIP RERLCDAVAV LLNMRNPDGG FATYETKRGG HLLELLNPSE
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of LSS antibody,
Alternative Names: LSS control peptide, LSS antibody Blocking Peptide, Anti-LSS Blocking Peptide, Lanosterol Synthase Blocking Peptide, 2,3-Oxidosqualene-Lanosterol Cyclase Blocking Peptide, OSC Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- LSS (Lanosterol Synthase (2,3-Oxidosqualene-Lanosterol Cyclase) (LSS))
-
Background
- LSS catalyzes the conversion of (S)-2,3 oxidosqualene to lanosterol. It is a member of the terpene cyclase/mutase family and catalyzes the first step in the biosynthesis of cholesterol, steroid hormones, and vitamin D. Two transcript variants encoding the same protein have been found for this gene.
-
Molecular Weight
- 83 kDa
Target
-